SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001557142-20-000088
Filing Date
2020-11-30
Accepted
2020-11-30 08:51:21
Documents
14
Period of Report
2020-11-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kdmn-20201130x8k.htm   iXBRL 8-K 85824
2 EX-99.1 kdmn-20201130xex99_1.htm EX-99.1 23599
3 GRAPHIC kdmn-20201130xex99_1g001.jpg GRAPHIC 14972
  Complete submission text file 0001557142-20-000088.txt   259593

Data Files

Seq Description Document Type Size
4 EX-101.SCH kdmn-20201130.xsd EX-101.SCH 3073
5 EX-101.LAB kdmn-20201130_lab.xml EX-101.LAB 15504
6 EX-101.PRE kdmn-20201130_pre.xml EX-101.PRE 11477
7 EXTRACTED XBRL INSTANCE DOCUMENT kdmn-20201130x8k_htm.xml XML 4862
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37841 | Film No.: 201356429
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences